Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
head and neck cancer
Pharma
Merck's Keytruda stages comeback in head and neck cancer
Merck & Co. hopes a new positive readout can return Keytruda to glory in head and neck cancer about two years after a prior failure.
Angus Liu
Oct 8, 2024 10:26am
Junshi, Coherus move Loqtorzi closer to another approval
Jun 12, 2024 11:45am
Coherus spurns 'heavily discounted' pricing for new PD-1 med
Oct 30, 2023 12:10pm
Vyvanse, Keytruda-Lenvima, Adagene-ADC—Fierce Pharma Asia
Sep 1, 2023 8:50am
Another Keytruda-Lenvima hope shattered at Merck, Eisai
Aug 25, 2023 10:35am
Merck KGaA starts educating HCPs on cancer's wall of resistance
Jun 26, 2023 10:24am
